SHIFERMAN GREGORY L. (See Remarks) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/11/2025ACC: 0001562180-25-003111
Officer· See Remarks
Since Nov 2024
+349.00
Net shares
Net buyer
$1.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
525.00 acquired · 176.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+525.00
Price / share
—
Trade value
—
% of position
1.7%
4/10/2025
30.68K→31.20K
Common Stock
Direct
Shares
−176.00
Price / share
$6.91
Trade value
$1.22K
% of position
0.6%
4/10/2025
31.20K→31.03K
Total
Net shares
+349.00
Net value
-$1.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/10/2025 | A · Award | +525.00 | — | — | 1.7% | 30.68K | 31.20K |
| Common Stock Direct | 4/10/2025 | F · Tax Withholding | −176.00 | $6.91 | $1.22K | 0.6% | 31.20K | 31.03K |
| Total | +349.00 | -$1.22K | ||||||
Derivative Transactions0
No derivative transactions reported